Gyre Therapeutics Financial Overview
Gyre Therapeutics's market cap is currently $648.05M. The company's EPS TTM is $0.03; its P/E ratio is 187.14; Gyre Therapeutics is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
